Cargando…
Sortilin inhibition limits secretion-induced progranulin-dependent breast cancer progression and cancer stem cell expansion
BACKGROUND: Cancer progression is influenced by genetic aberrations in the cancer cell population as well as by other factors including the microenvironment present within a tumour. Direct interactions between various cell types as well as cellular signalling via secreted cytokines can drive key tum...
Autores principales: | Rhost, Sara, Hughes, Éamon, Harrison, Hannah, Rafnsdottir, Svanheidur, Jacobsson, Hanna, Gregersson, Pernilla, Magnusson, Ylva, Fitzpatrick, Paul, Andersson, Daniel, Berger, Karoline, Ståhlberg, Anders, Landberg, Göran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245804/ https://www.ncbi.nlm.nih.gov/pubmed/30454027 http://dx.doi.org/10.1186/s13058-018-1060-5 |
Ejemplares similares
-
Tumor co-expression of progranulin and sortilin as a prognostic biomarker in breast cancer
por: Berger, Karoline, et al.
Publicado: (2021) -
Hypoxia‐induced secretion stimulates breast cancer stem cell regulatory signalling pathways
por: Jacobsson, Hanna, et al.
Publicado: (2019) -
Patient-derived scaffolds influence secretion profiles in cancer cells mirroring clinical features and breast cancer subtypes
por: Persson, Emma, et al.
Publicado: (2021) -
Characterization of cell-free breast cancer patient-derived scaffolds using liquid chromatography-mass spectrometry/mass spectrometry data and RNA sequencing data
por: Landberg, Göran, et al.
Publicado: (2020) -
The mevalonate precursor enzyme HMGCS1 is a novel marker and key mediator of cancer stem cell enrichment in luminal and basal models of breast cancer
por: Walsh, Claire A., et al.
Publicado: (2020)